Snapshot
Idex Corp /De/ reported $865M of revenue in Q2 2025, up 7.2% year over year, with diluted EPS of $1.74 and an operating margin of 21.7%.
- Revenue
- $865M
- YoY growth
- +7.2%
- Diluted EPS
- $1.74
- Operating margin
- 21.7%
$865M
Revenue
+7.2%
YoY growth
$1.74
Diluted EPS
21.7%
Operating margin
01 Key takeaways
What management said
- •We released our second quarter financial results earlier this morning, and you can find both our press release and earnings call slide presentation in the Investor Relations section of our website, idexcorp.com.
- •I'd like to walk through a real-time growth example of this dynamic tuning at Airtech, a business acquired in 2021 within HST, to illustrate our team's agility in action.
- •Four years ago, at the time of acquisition, their product lines were growing within mutually exclusive application sets supported by good operational performance with room for targeted improvements.
- •It demonstrates the power of our dynamic business model, our commitment to 80/20, and the leverage of IDEX's global capabilities with proprietary capital deployment via M&A as the key catalyst.
- •We're confident in the pneumatics team's plans to drive even more growth and value creation in the quarters and years to come.
- •Within Q2, there were some strong demand influence in the form of trade policy positioning statements that were unpredictable, shocking the system and setting up sine waves of up-and-down order patterns.
- •Daily demand levels moved dynamically between policy announcements and negotiation deadlines as customers attempted to de-risk tariff and pricing exposure.
- •Second, and most important for us, the sudden and unpredictable shifts in policy are slowing down decision-making and conviction for larger orders.
- •This has the highest go-forward impact for us in some more recently acquired areas of IDEX, where strong growth funnels supported earlier expectations of accelerating back half revenue and margins.
- •Coupling this with our long-established operational capabilities, we believe we are very well positioned to drive attractive growth and value for all of our stakeholders.
- •Our goal is simple: extend IDEX's growth potential through variable levels of integration to win in advantaged markets where customers are demanding more solutions impact than any one single business unit can provide alone.
- •First is HST's IDEX Health & Science platform that we built through thoughtful capital deployment over the last 20 years.
SourcesCompany financials · earnings call
Last updated